Transthyretin amyloidosis Clinical Trials

Delta Trials catalogs 36 clinical trials for Transthyretin amyloidosis in its publicly accessible dataset. Within this set, 7 currently recruiting participants and 19 trials have reached completion. This research occurs across 268 participating sites around the world. An additional 10 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 1 trial were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.